Healthcare law firm Frier Levitt has analyzed FDA enforcement actions from “exploration only” peptide sellers. Their summary: the FDA considers an item’s classification based upon its supposed use, not its disclaimers. When Internet sites incorporate dosage guides, reconstitution Recommendations, or website link to boards speaking about human